{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-047373","form_type":"8-K","ticker":"TLSI","cik":"0001826667","company_name":"TriSalus Life Sciences, Inc.","filed_at":"2024-04-16T23:59:59+00:00","discovered_at":"2026-05-14T18:03:20.447892+00:00","generated_at":"2026-06-03T22:23:35.560709+00:00","sec_items":["4.01","9.01"],"event_type":"other_material","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"TriSalus dismisses KPMG, hires Grant Thornton; KPMG cited going concern","bullets":["Dismissed KPMG as auditor on April 12, 2024; KPMG's reports included a going concern emphasis citing recurring losses.","Engaged Grant Thornton LLP as new independent registered public accounting firm for FY 2024.","No disagreements with KPMG on accounting principles; but material weaknesses in internal controls were disclosed.","Material weaknesses: insufficient trained resources, inadequate controls over business combination, warrant valuation, and equity system conversion.","KPMG's audit reports for 2022 and 2023 contained a separate paragraph on substantial doubt about going concern."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-047373","json":"https://secwatch.observer/filing/0001104659-24-047373.json","markdown":"https://secwatch.observer/filing/0001104659-24-047373.md","text":"https://secwatch.observer/filing/0001104659-24-047373.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1826667/000110465924047373/0001104659-24-047373-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1826667/000110465924047373/tm2411884d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-03T22:23:35.560709+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"92842f09462334b7619de6d45f6e58b0ab46ac50","claim":"TriSalus Life Sciences, Inc. engaged Grant Thornton LLP as its auditor.","evidence_excerpt":"On April 12, 2024, the Audit Committee approved the engagement of Grant Thornton LLP","evidence_source":"SEC 8-K Item 4.01/4.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1826667/000110465924047373/0001104659-24-047373-index.htm","confidence":0.9,"family_label":"Auditor Changes","details":[{"label":"Action","value":"engagement"},{"label":"Auditor","value":"Grant Thornton LLP"}],"fact_type":"auditor_change"},{"claim_id":"b1bc614e8ba9b751ad22f7aefae97cfe47a057a2","claim":"TriSalus Life Sciences, Inc. dismissed KPMG LLP as its auditor.","evidence_excerpt":"(a) Dismissal of Independent Registered Public Accounting Firm On April 12, 2024, the Audit Committee (the “Audit Committee”) of the Board of Directors of TriSalus Life Sciences, Inc. (the “Company”) approved the dismissal of KPMG LLP (“KPMG”) as the Company’s independent registered public accounting firm. On April 12, 2024, KPMG was informed that they were dismissed. KPMG’s audit reports on the Company’s consolidated financial statements as of and for the years ended December 31, 2023 and 2022, did not contain any adverse opinion or a disclaimer","evidence_source":"SEC 8-K Item 4.01/4.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1826667/000110465924047373/0001104659-24-047373-index.htm","confidence":0.9,"family_label":"Auditor Changes","details":[{"label":"Action","value":"dismissal"},{"label":"Auditor","value":"KPMG LLP"},{"label":"Successor","value":"Grant Thornton LLP"}],"fact_type":"auditor_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}